Skip navigation
A service of the
zbw
Contact
|
Imprint
|
Privacy
|
Sitemap
|
Accessibility
|
Deutsch
Home
About EconStor
About EconStor
Policy
News
Terms of use
Usage statistics
Submit
for:
institutions
authors
Search
Browse by
Author
Year of Publication
Document Type
Communities & Collections
Journals
Monographs (by Publishers)
References
FAQ
Open Access
Contact
Imprint
Privacy
Sitemap
Deutsch
Home
About EconStor
Policy
submit for institutions
submit for authors
Search
browse by Author
browse by Year of Publication
browse by Document Type
browse by Communities & Collections
browse by Journals
browse by Monographs (by Publishers)
News
Terms of use
Usage statistics
References
FAQ
Open Access
EconStor
Search
Search in:
All of EconStor
Springer Nature
China Finance and Economic Review, SpringerOpen
Decision Analytics, SpringerOpen
Financial Innovation (FIN), SpringerOpen
Health Economics Review: a SpringerOpen Journal
International Journal of Quality Innovation, SpringerOpen
Journal of Chinese Management, SpringerOpen
Journal of Global Entrepreneurship Research, SpringerOpen
Journal of Innovation and Entrepreneurship: a SpringerOpen Journal
Journal of Remanufacturing, Springer
Open Access Articles from the Springer-DEAL Agreement, Springer Nature
Springer Nature, Open Access Books
for
Current filters:
Title
Author
Subject
DDC
Date Issued
Has File(s)
Filename
File description
id
jel
series
language (ISO)
document type
ISBN
citation
ppn
Session
Journal - issue
Journal - volume
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
DDC
Date Issued
Has File(s)
Filename
File description
id
jel
series
language (ISO)
document type
ISBN
citation
ppn
Journal - issue
Journal - volume
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-5 of 5.
Back
1
Next
Item hits:
Year of Publication
Title
Author(s)
2016
Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany: Are additional data requirements by the Federal Joint Committee justified?
Ruof, Jörg
;
Staab, Thomas
;
Dintsios, Charalabos-Markos
;
Schröter, Jakob
;
Schwartz, Friedrich Wilhelm
2018
Market withdrawals' of medicines in Germany after AMNOG: A comparison of HTA ratings and clinical guideline recommendations
Staab, Thomas R.
;
Walter, Miriam
;
Mariotti Nesurini, Sonja
;
Dintsios, Charalabos-Markos
;
von der Schulenburg, Johann-Matthias
;
Amelung, Volker E.
;
Ruoff, Jörg
2021
How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG?
Dintsios, Charalabos-Markos
;
Chernyak, Nadja
2020
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin
;
Schüßler, Sofia
;
Hammerschmidt, Thomas
;
Dintsios, Charalabos-Markos
2014
Patient relevant endpoints in oncology: Current issues in the context of early benefit assessment in Germany
Dabisch, Inna
;
Dethling, Jürgen
;
Dintsios, Charalabos-Markos
;
Drechsler, Melanie
;
Kalanovic, Daniel
;
Kaskel, Peter
;
Langer, Frank
;
Ruof, Jörg
;
Ruppert, Thorsten
;
Wirth, Daniel
Author
2
Ruof, Jörg
1
Amelung, Volker E.
1
Chernyak, Nadja
1
Dabisch, Inna
1
Dethling, Jürgen
1
Drechsler, Melanie
1
Gandjour, Afschin
1
Hammerschmidt, Thomas
1
Kalanovic, Daniel
1
Kaskel, Peter
.
next >
year of Publication
1
2021
1
2020
1
2018
1
2016
1
2014